Compare Bio Protocol (BIO) vs NEAR Protocol (NEAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs NEAR Protocol — how do they compare? Bio Protocol trades at Rp437.67 (market cap Rp997,43M, Rp162,4M 24h volume), while NEAR Protocol trades at Rp28,623 (market cap Rp37,02T, Rp1,88T 24h volume). The key difference: NEAR Protocol is far larger — about 37115.4× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while NEAR Protocol's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and NEAR Protocol for 51 Days on average.
| BIO | NEAR | |
|---|---|---|
Market Cap | Rp997,43M | Rp37,02T |
Volume (24h) | Rp162,4M | Rp1,88T |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,3B NEAR |
Typical Hold Time | 18 Days | 51 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
NEAR Protocol is currently trading at Rp28,485 with a market cap of Rp37.25T, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp29,779 and support at Rp28,880, with RSI levels suggesting neither overbought nor oversold conditions. Recent news highlights NEAR's positioning as a potential beneficiary in a lower interest rate environment.
Overall outlook remains cautious with bearish technical momentum but neutral oscillators. Key opportunities include protocol positioning for potential rate cuts, while risks include continued selling pressure and crypto market volatility. Investors should monitor support levels and broader market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About NEAR Protocol
NEAR is a sharded, developer-friendly, proof-of-stake public blockchain, built by a world-class team that has built some of the world's only sharded databases at scale. The network runs on a Proof-of-Stake (PoS) convention mechanism called Nightshade, which aims to offer scalability and stable costs. nn
Read more on NEAR →
